Kapitalo Investimentos Ltda Vertex Pharmaceuticals Inc Transaction History

Kapitalo Investimentos Ltda

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$407.69 - $446.08 $60,745 - $66,465	149 Added 25.34%	737 $308 Million
Q4 2023 Mar 29, 2024	BUY	$343.0 - $410.68 $201,684 - $241,479	588 New	588 $239 Million
Q3 2023 Mar 29, 2024	SELL	$338.18 - $362.46 $210,686 - $225,812	-623 Closed	0 $0
Q2 2023 Mar 29, 2024	BUY	$314.42 - $351.91 $195,883 - $219,239	623 New	623 $219 Million

1,707

226M

1.2M

1.59M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $122B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Kapitalo Investimentos Ltda, based on Form 13F filings with the SEC.

Stay updated on Kapitalo Investimentos Ltda with notifications on news.